ValiRx (VAL) News Today GBX 1.68 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ValiRx Secures Funding for Prostate Cancer ResearchNovember 22 at 11:43 AM | markets.businessinsider.comValiRX adds to streak of deals with cancer cell test materials winNovember 19, 2024 | lse.co.ukAIM WINNERS & LOSERS: Woodbois subscription raises over GBP1 millionNovember 19, 2024 | lse.co.ukValiRx Marks Milestone with New Product LaunchNovember 18, 2024 | msn.comPhilip Morris raises annual guidance as higher cigarette prices fuel earnings beatOctober 23, 2024 | msn.comEARNINGS: Kendrick Resources loss narrows; Emmerson CFO to departSeptember 27, 2024 | lse.co.ukValiRx plc (VAL.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comNo savings after inflation? I’d use the Warren Buffett method to build wealthSeptember 18, 2024 | msn.comValiRx Share Chat (VAL)September 17, 2024 | lse.co.ukTRADING UPDATES: Light Science Technologies wins two new contractsSeptember 10, 2024 | lse.co.ukCornish Metals Inc.: Cornish Metals Appoints Don Turvey as Chief Executive OfficerAugust 13, 2024 | finanznachrichten.dePublication of Final TermsAugust 1, 2024 | lse.co.ukValiRx PLC VALMay 26, 2024 | morningstar.comLONDON MARKET CLOSE: London gets boost thanks to rate cut hopesMay 20, 2024 | lse.co.ukValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grantMay 20, 2024 | lse.co.ukEARNINGS AND TRADING: Tullow Oil on track to hit free cash flow targetMay 16, 2024 | lse.co.ukTRADING UPDATES: Vertu Motors ups dividend as hails record revenueMay 15, 2024 | lse.co.ukNew method discovered to halt active cancer cellsFebruary 28, 2024 | msn.comScientists discover 'two-punch' method to eliminate cancer cellsFebruary 27, 2024 | uk.news.yahoo.comValiRx says requisition notice from shareholder group is invalidFebruary 13, 2024 | lse.co.ukTRADING UPDATES: ValiRx receives shareholder request for board changeFebruary 9, 2024 | lse.co.ukEuropean Stocks Close Mostly HigherDecember 5, 2023 | markets.businessinsider.comEuropean Markets Move Mostly HigherDecember 5, 2023 | markets.businessinsider.comValiRx says ValiSeek inks deal to licence VAL401 drug with AmbroseDecember 5, 2023 | lse.co.ukValiRx PLC EAJFNovember 15, 2023 | morningstar.comValiRx signs deal to evaluate StingRay Bio drug candidatesNovember 10, 2023 | lse.co.ukCORRECT (Oct 5): ICG Enterprise ups interim payout on better resultsOctober 6, 2023 | lse.co.ukValiRx sees no reason for shares jump; notes TheoremRx mulls mergerOctober 6, 2023 | lse.co.ukVAL.L - ValiRx plcSeptember 11, 2023 | finance.yahoo.comValiRx interim loss widens as costs increase; hails Inaphaea progressAugust 24, 2023 | lse.co.ukValiRx Shares Rise on Higher Income Expectations From Inaphaea BioLabsAugust 24, 2023 | marketwatch.comValiRx signs collaborative services agreement with AgilityAugust 14, 2023 | lse.co.ukValiRx Shares Rise After Collaborative Services Agreement With AgilityAugust 14, 2023 | marketwatch.comValiRx Shares Rise After Subsidiary Secures ContractJuly 19, 2023 | marketwatch.comTRADING UPDATES: All Things Considered raises funds to buy SandbagJune 28, 2023 | lse.co.ukValiRx shares drop after cancer drug research droppedJune 16, 2023 | lse.co.ukValiRx Shares Fall After Cancer-Drug Development AbandonedJune 16, 2023 | marketwatch.comValiRx Changes IP Exclusivity Terms With TheoremRx to Exclude Greater ChinaJune 8, 2023 | marketwatch.comValiRx expands cancer research agreement with University of BarcelonaJune 7, 2023 | lse.co.ukSelf Storage Gr Share ChatJune 3, 2023 | lse.co.ukMilner Therapeutics Institute welcomes Cathy Tralau-Stewart as executive directorMay 4, 2023 | msn.comGlobal Endometriosis Drugs Market Research Growth, Regions, Type and Application, Forecast Analysis to 2023-2030 By VMReportsMarch 26, 2023 | marketwatch.comSuzy Dilly, ValiRx CEO reiterates her support for TheoremRx and hails 'brilliant science' CytolytixNovember 10, 2022 | lse.co.ukValiRx teams with King's College London for cancer projectOctober 25, 2022 | lse.co.ukValiRx Shares Rise on Subsidiary's Intellectual Property License AgreementOctober 25, 2022 | marketwatch.comGlobal Endometriosis Drugs Market to Reach $2.9 Billion by 2027 - Yahoo FinanceOctober 18, 2022 | finance.yahoo.comValiRx Plc - Ada Lovelace Day 2022, in conversation with ValiRx's CEO - Marketscreener.comOctober 12, 2022 | marketscreener.comUK announces 40 billion-pound liquidity plan for power firms | Financial News - London South EastSeptember 8, 2022 | lse.co.ukUK plans to hold a "fiscal event" this month | Financial News - London South EastSeptember 8, 2022 | lse.co.ukValiRx Names Catherine Tralau-Stewart as Interim Chief Scientific Officer - MarketWatchSeptember 8, 2022 | marketwatch.com Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin VAL Media Mentions By Week VAL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VAL News Sentiment▼-0.490.49▲Average Medical News Sentiment VAL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VAL Articles This Week▼40▲VAL Articles Average Week Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Europa Oil & Gas News Nostrum Oil & Gas News Surgical Innovations Group News EQTEC News Webis News Shell News BP News Woodside Energy Group News Melrose Industries News Bridgepoint Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:VAL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
